US Stock MarketDetailed Quotes

Keros Therapeutics (KROS)

Watchlist
  • 19.210
  • -0.250-1.28%
Trading Jan 23 12:33 ET
585.25MMarket Cap12.31P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Keros Therapeutics (KROS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
3,575.77%14.26M
49,002.70%18.17M
254,413.25%211.25M
2,250.99%3.55M
2,027.27%3.04M
4,750.00%388K
37K
83K
151K
143K
Operating revenue
3,575.77%14.26M
49,002.70%18.17M
254,413.25%211.25M
2,250.99%3.55M
2,027.27%3.04M
4,750.00%388K
--37K
--83K
--151K
--143K
Cost of revenue
Gross profit
Operating expense
-49.79%29.65M
14.88%57.99M
21.91%59.21M
27.11%213.15M
24.57%55.06M
36.40%59.05M
22.11%50.48M
24.95%48.57M
55.69%167.69M
38.29%44.2M
Selling and administrative expenses
3.13%10.13M
45.39%14.48M
1.83%10.5M
16.99%40.75M
17.13%10.67M
7.35%9.82M
13.15%9.96M
32.53%10.31M
26.55%34.83M
28.37%9.11M
-General and administrative expense
3.13%10.13M
45.39%14.48M
1.83%10.5M
16.99%40.75M
17.13%10.67M
7.35%9.82M
13.15%9.96M
32.53%10.31M
26.55%34.83M
28.37%9.11M
Research and development costs
-60.35%19.52M
7.38%43.5M
27.32%48.71M
28.37%173.63M
21.71%45.63M
44.19%49.23M
24.53%40.52M
23.05%38.26M
55.00%135.26M
50.77%37.49M
Other operating expenses
----
----
----
48.42%-1.24M
----
----
----
----
66.11%-2.4M
----
Operating profit
73.77%-15.38M
21.06%-39.82M
413.59%152.04M
-25.10%-209.6M
-18.07%-52.02M
-35.53%-58.66M
-22.02%-50.44M
-24.73%-48.48M
-55.55%-167.54M
-37.84%-44.06M
Net non-operating interest income expense
0
0
Non-operating interest expense
----
----
----
--0
----
----
----
----
--0
----
Other net income (expense)
17.17%6.68M
33.13%6.9M
20.21%6.45M
54.94%22.54M
65.01%6.29M
48.46%5.7M
35.23%5.18M
75.17%5.37M
380.01%14.55M
70.03%3.81M
Gain on sale of security
19.68%6.93M
32.39%7.12M
16.98%6.79M
59.24%23.5M
73.56%6.52M
48.27%5.79M
34.89%5.38M
86.99%5.81M
304.91%14.76M
--3.76M
Other non- operating income (expenses)
-175.00%-253K
-12.76%-221K
22.65%-338K
-363.11%-954K
-508.93%-229K
-37.31%-92K
-26.45%-196K
-992.50%-437K
66.39%-206K
103.99%56K
Income before tax
83.56%-8.7M
27.26%-32.92M
467.62%158.49M
-22.26%-187.05M
-13.62%-45.73M
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
-46.15%-152.99M
-35.42%-40.24M
Income tax
-1.42M
-2.22M
10.04M
300K
300K
0
0
0
0
Net income
86.25%-7.28M
32.17%-30.7M
444.32%148.45M
-22.46%-187.35M
-14.37%-46.03M
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
-46.15%-152.99M
-35.42%-40.24M
Net income continuous Operations
86.25%-7.28M
32.17%-30.7M
444.32%148.45M
-22.46%-187.35M
-14.37%-46.03M
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
-46.15%-152.99M
-35.42%-40.24M
Minority interest income
Net income attributable to the parent company
86.25%-7.28M
32.17%-30.7M
444.32%148.45M
-22.46%-187.35M
-14.37%-46.03M
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
-46.15%-152.99M
-35.42%-40.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
86.25%-7.28M
32.17%-30.7M
444.32%148.45M
-22.46%-187.35M
-14.37%-46.03M
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
-46.15%-152.99M
-35.42%-40.24M
Basic earnings per share
87.23%-0.18
39.20%-0.76
402.48%3.66
3.85%-5
14.93%-1.14
-6.02%-1.41
1.57%-1.25
3.97%-1.21
-25.30%-5.2
-22.94%-1.34
Diluted earnings per share
87.23%-0.18
39.20%-0.76
399.17%3.62
3.85%-5
14.93%-1.14
-6.02%-1.41
1.57%-1.25
3.97%-1.21
-25.30%-5.2
-22.94%-1.34
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 3,575.77%14.26M49,002.70%18.17M254,413.25%211.25M2,250.99%3.55M2,027.27%3.04M4,750.00%388K37K83K151K143K
Operating revenue 3,575.77%14.26M49,002.70%18.17M254,413.25%211.25M2,250.99%3.55M2,027.27%3.04M4,750.00%388K--37K--83K--151K--143K
Cost of revenue
Gross profit
Operating expense -49.79%29.65M14.88%57.99M21.91%59.21M27.11%213.15M24.57%55.06M36.40%59.05M22.11%50.48M24.95%48.57M55.69%167.69M38.29%44.2M
Selling and administrative expenses 3.13%10.13M45.39%14.48M1.83%10.5M16.99%40.75M17.13%10.67M7.35%9.82M13.15%9.96M32.53%10.31M26.55%34.83M28.37%9.11M
-General and administrative expense 3.13%10.13M45.39%14.48M1.83%10.5M16.99%40.75M17.13%10.67M7.35%9.82M13.15%9.96M32.53%10.31M26.55%34.83M28.37%9.11M
Research and development costs -60.35%19.52M7.38%43.5M27.32%48.71M28.37%173.63M21.71%45.63M44.19%49.23M24.53%40.52M23.05%38.26M55.00%135.26M50.77%37.49M
Other operating expenses ------------48.42%-1.24M----------------66.11%-2.4M----
Operating profit 73.77%-15.38M21.06%-39.82M413.59%152.04M-25.10%-209.6M-18.07%-52.02M-35.53%-58.66M-22.02%-50.44M-24.73%-48.48M-55.55%-167.54M-37.84%-44.06M
Net non-operating interest income expense 00
Non-operating interest expense --------------0------------------0----
Other net income (expense) 17.17%6.68M33.13%6.9M20.21%6.45M54.94%22.54M65.01%6.29M48.46%5.7M35.23%5.18M75.17%5.37M380.01%14.55M70.03%3.81M
Gain on sale of security 19.68%6.93M32.39%7.12M16.98%6.79M59.24%23.5M73.56%6.52M48.27%5.79M34.89%5.38M86.99%5.81M304.91%14.76M--3.76M
Other non- operating income (expenses) -175.00%-253K-12.76%-221K22.65%-338K-363.11%-954K-508.93%-229K-37.31%-92K-26.45%-196K-992.50%-437K66.39%-206K103.99%56K
Income before tax 83.56%-8.7M27.26%-32.92M467.62%158.49M-22.26%-187.05M-13.62%-45.73M-34.27%-52.96M-20.67%-45.26M-20.42%-43.11M-46.15%-152.99M-35.42%-40.24M
Income tax -1.42M-2.22M10.04M300K300K0000
Net income 86.25%-7.28M32.17%-30.7M444.32%148.45M-22.46%-187.35M-14.37%-46.03M-34.27%-52.96M-20.67%-45.26M-20.42%-43.11M-46.15%-152.99M-35.42%-40.24M
Net income continuous Operations 86.25%-7.28M32.17%-30.7M444.32%148.45M-22.46%-187.35M-14.37%-46.03M-34.27%-52.96M-20.67%-45.26M-20.42%-43.11M-46.15%-152.99M-35.42%-40.24M
Minority interest income
Net income attributable to the parent company 86.25%-7.28M32.17%-30.7M444.32%148.45M-22.46%-187.35M-14.37%-46.03M-34.27%-52.96M-20.67%-45.26M-20.42%-43.11M-46.15%-152.99M-35.42%-40.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 86.25%-7.28M32.17%-30.7M444.32%148.45M-22.46%-187.35M-14.37%-46.03M-34.27%-52.96M-20.67%-45.26M-20.42%-43.11M-46.15%-152.99M-35.42%-40.24M
Basic earnings per share 87.23%-0.1839.20%-0.76402.48%3.663.85%-514.93%-1.14-6.02%-1.411.57%-1.253.97%-1.21-25.30%-5.2-22.94%-1.34
Diluted earnings per share 87.23%-0.1839.20%-0.76399.17%3.623.85%-514.93%-1.14-6.02%-1.411.57%-1.253.97%-1.21-25.30%-5.2-22.94%-1.34
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.08%
Sample Name
Sample Code
 +3.97%
Sample Name
Sample Code
 +2.96%
4
Amazon
AMZN
+2.28%
5
NVIDIA
NVDA
+1.69%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.16%
Sample Name
Sample Code
 +8.92%
Sample Name
Sample Code
 +5.23%
4
KE Holdings
BEKE
+4.42%
5
H World Group
HTHT
+4.17%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -